| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy;
Department of Pathology, Section of General Pathology, University of Verona, Verona, Italy;
Department of Pediatrics, University of Brescia, Brescia, Italy;
Department of Biomedical Sciences and Biotechnology, Unit of General Pathology and Immunology, University of Brescia, Brescia, Italy; and
¶
Department of Microbiology, University of Turin, Turin, Italy
Activation of NADPH oxidase represents an essential mechanism of defense against pathogens. Dendritic cells (DC) are phagocytic cells specialized in Ag presentation rather than in bacteria killing. Human monocyte-derived DC were found to express the NADPH oxidase components and to release superoxide anions in response to phorbol esters and phagocytic agonists. The NADPH oxidase components p47phox and gp91phox were down-regulated during monocyte differentiation to DC, and maturation of DC with pathogen-derived molecules, known to activate TLRs, increased p47phox and gp91phox expression and enhanced superoxide anions release. Similar results were obtained with plasmacytoid DC following maturation with influenza virus. In contrast, activation of DC by immune stimuli (CD40 ligand) did not regulate NADPH oxidase components or respiratory burst. NADPH oxidase-derived oxygen radicals did not play any role in DC differentiation, maturation, cytokine production, and induction of T cell proliferation, as based on the normal function of DC generated from chronic granulomatous disease patients and the use of an oxygen radical scavenger. However, NADPH oxidase activation was required for DC killing of intracellular Escherichia coli. It is likely that the selective regulation of oxygen radicals production by pathogen-activated DC may function to limit pathogen dissemination during DC trafficking to secondary lymphoid tissues.
This article has been cited by other articles:
|
|
 |
|
  C. D'Angelo, A. De Luca, T. Zelante, P. Bonifazi, S. Moretti, G. Giovannini, R. G. Iannitti, S. Zagarella, S. Bozza, S. Campo, et al. Exogenous Pentraxin 3 Restores Antifungal Resistance and Restrains Inflammation in Murine Chronic Granulomatous Disease J. Immunol., October 1, 2009; 183(7): 4609 - 4618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Yang, D.-M. Shin, K.-H. Kim, Z.-W. Lee, C.-H. Lee, S. G. Park, Y. S. Bae, and E.-K. Jo NADPH Oxidase 2 Interaction with TLR2 Is Required for Efficient Innate Immune Responses to Mycobacteria via Cathelicidin Expression J. Immunol., March 15, 2009; 182(6): 3696 - 3705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Mantegazza, A. Savina, M. Vermeulen, L. Perez, J. Geffner, O. Hermine, S. D. Rosenzweig, F. Faure, and S. Amigorena NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells Blood, December 1, 2008; 112(12): 4712 - 4722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Into, M. Inomata, M. Nakashima, K.-i. Shibata, H. Hacker, and K. Matsushita Regulation of MyD88-Dependent Signaling Events by S Nitrosylation Retards Toll-Like Receptor Signal Transduction and Initiation of Acute-Phase Immune Responses Mol. Cell. Biol., February 15, 2008; 28(4): 1338 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Karlsson, E. Nygren, J. Karlsson, I. Nordstrom, C. Dahlgren, and K. Eriksson Ability of Monocyte-Derived Dendritic Cells To Secrete Oxygen Radicals in Response to Formyl Peptide Receptor Family Agonists Compared to That of Myeloid and Plasmacytoid Dendritic Cells Clin. Vaccine Immunol., March 1, 2007; 14(3): 328 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sinha, A. Singh, V. Satchidanandam, and K. Natarajan Impaired Generation of Reactive Oxygen Species during Differentiation of Dendritic Cells (DCs) by Mycobacterium tuberculosis Secretory Antigen (MTSA) and Subsequent Activation of MTSA-DCs by Mycobacteria Results in Increased Intracellular Survival J. Immunol., July 1, 2006; 177(1): 468 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fontana, S. Parolini, W. Vermi, S. Booth, F. Gallo, M. Donini, M. Benassi, F. Gentili, D. Ferrari, L. D. Notarangelo, et al. Innate immunity defects in Hermansky-Pudlak type 2 syndrome Blood, June 15, 2006; 107(12): 4857 - 4864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Vermi, F. Facchetti, E. Riboldi, H. Heine, S. Scutera, S. Stornello, D. Ravarino, P. Cappello, M. Giovarelli, R. Badolato, et al. Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma Blood, January 15, 2006; 107(2): 454 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Riboldi, T. Musso, E. Moroni, C. Urbinati, S. Bernasconi, M. Rusnati, L. Adorini, M. Presta, and S. Sozzani Cutting Edge: Proangiogenic Properties of Alternatively Activated Dendritic Cells J. Immunol., September 1, 2005; 175(5): 2788 - 2792. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
